Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder

Mar 1, 2013, 00:00 AM
10.1016/j.jval.2012.12.005
https://www.valueinhealthjournal.com/article/S1098-3015(12)04271-4/fulltext
Section Title : Preference-Based Assessments
Section Order : 18
First Page : 394

Objectives

To provide a mapping algorithm for estimating EuroQol five-dimensional (EQ-5D) questionnaire index scores from the Incontinence-specific Quality of Life questionnaire (I-QOL) based on nationally representative samples of patients with idiopathic or neurogenic overactive bladder (OAB) using EQ-5D questionnaire preference valuations based on both the UK and US general populations.

Methods

Analyses were conducted for 2505 patients from the Adelphi Overactive Bladder Disease Specific Programme, a cross-sectional study of patients with idiopathic or neurogenic OAB, undertaken in the United States and Europe in 2010. A range of statistical modeling techniques was used. Tenfold cross-validation techniques were used to calculate mean absolute error (MAE) and root mean squared error (RMSE) goodness-of-fit statistics. Various predictor lists, together with a method combining stepwise selection with multivariable fractional polynomial techniques to allow nonlinear relationships to feature, were pursued.

Results

Choice of predictors was consistent for both the UK and US EQ-5D questionnaire tariffs. For idiopathic, the best model included the I-QOL total score and age (both modeled nonlinearly.) For neurogenic, the best model was the I-QOL social embarrassment domain score modeled linearly only. Best-fit results were better in the idiopathic (n = 2351; MAE = 0.10; RMSE = 0.14) than in the neurogenic sample (n = 254; MAE = 0.17; RMSE = 0.22).

Conclusions

This research provides algorithms for mapping EQ-5D questionnaire index scores from the I-QOL, allowing calculation of appropriate preference-based health-related quality-of-life scores for use in cost-effectiveness analyses when only I-QOL data are available. The strongest results were for idiopathic patients, but those for neurogenic are consistent with those of other published mapping studies.

https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)04271-4&doi=10.1016/j.jval.2012.12.005
HEOR Topics :
  • Health State Utilities
  • Instrument Development, Validation, & Translation
  • Patient-Centered Research
  • Specific Diseases & Conditions
  • Urinary/Kidney Disorders
Tags :
  • cross-walk
  • EQ-5D
  • I-QOL
  • mapping
  • real world
  • utility values
Regions :
  • Eastern and Central Europe
  • North America